William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Downgrades On Holding AG (ONON) to Market Perform
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Jun 30
-
William Blair Assumes Applied Materials (AMAT) at Market Perform
-
On Holding Q2 seen holding strong as spending data counters July search slowdown
-
Silence Therapeutics launches $150 million ADS public offering
-
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
-
William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform
-
Lyntris launches IPO at $19-$22 per share on NYSE
-
Lyntris Inc. Announces Launch of its Initial Public Offering
-
William Blair Starts Standard Nuclear (STDN) at Outperform
-
William Blair cites tight labor market in staffing stock outlook
-
KKR closes equity investment in Crowe Advisory LLC
-
Crowe closes strategic investment from KKR
-
Remitly Announces Upcoming Webinar and Investor Conference Participation
-
William Blair Upgrades Dropbox (DBX) to Market Perform
-
Abry Partners Exits Investment in Prime Capital Financial Following Period of Significant Growth
-
Carlyle takes minority stake in Prime Capital Financial at $1.8B value
-
Prime Capital Financial Announces Strategic Partnership With Carlyle to Accelerate Next Phase of Growth
-
William Blair Downgrades EPAM Systems (EPAM) to Market Perform
-
William Blair Downgrades Zoetis Inc. (ZTS) to Market Perform, 'Changing Commercial Strategies Create Too Much Uncertainty on the P&L'
-
Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing
-
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
-
William Blair Downgrades LegalZoom.com Inc (LZ) to Market Perform
-
William Blair Positive on Axon Enterprise (AXON): 'ARR Shows Acceleration to 39% Growth Supported by 41% FCB Growth'
-
Form 497 William Blair ETF Trust
-
Kforce Inc. to Participate in the William Blair Human Capital Services Virtual Conference
-
William Blair on Circle Internet Group (CRCL): 'Leaders Lead'
-
William Blair Downgrades Suja Life Inc. (SUJA) to Market Perform
-
Circle shares fall as revenue miss overshadows quarterly profit beat
-
William Blair Reiterates Outperform Rating on SpaceX (SPCX)
-
William Blair Downgrades Procept BioRobotics Corp (PRCT) to Market Perform
-
Twist Bioscience prices $300M public offering at $96 per share
-
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
-
Twist Bioscience proposes $250M common stock offering
-
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
-
SK Hynix rises as brokerages launch coverage with bullish ratings
-
William Blair on Palantir (PLTR): 'stellar performance defies concerns that competition with Anthropic and OpenAI is intensifying'
-
William Blair Starts SK Hynix (SKHY) at Outperform
-
William Blair Downgrades Lantheus Holdings (LNTH) to Market Perform
-
Obsidian Therapeutics completes Galera merger, raises $350M
-
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million
-
William Blair Downgrades Birkenstock Holding plc (BIRK) to Market Perform
-
William Blair Adds GE Vernova (GEV) to Conviction List
-
William Blair Updates Analyst Conviction List For August 2026
-
Jersey Mike's closes IPO at $23 per share on NYSE
-
Jersey Mike’s Announces Closing of Initial Public Offering
-
Coinbase shares take hit on quarterly loss, analysts back diversification strategy
-
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates
-
William Blair Reiterates Outperform Rating on SPX Technologies (SPXC)
-
Perimeter Solutions Reports Second Quarter 2026 Financial Results

